A new study examines how cost, side effects and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback